Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$546M |
| 2 |
Microsoft
MSFT
|
+$480M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$362M |
| 4 |
Meta Platforms (Facebook)
META
|
+$350M |
| 5 |
Coca-Cola
KO
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Robinhood
HOOD
|
+$1.04B |
| 2 |
Palantir
PLTR
|
+$800M |
| 3 |
Apple
AAPL
|
+$516M |
| 4 |
Netflix
NFLX
|
+$326M |
| 5 |
NVIDIA
NVDA
|
+$313M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.71% |
| 2 | Healthcare | 15.16% |
| 3 | Consumer Discretionary | 11.81% |
| 4 | Communication Services | 10.53% |
| 5 | Financials | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3101
Dimensional US Targeted Value ETF
DFAT
$14.9B
| $227K | ﹤0.01% |
3,900
-18,900
| -83% | -$1.08M |
|
|
GRO
3102
Brazil Potash Corp
GRO
$131M
| $227K | ﹤0.01% |
84,325
+50,025
| +146% | +$95.8K |
|
3103
Ebang International Holdings
EBON
$11.7M
| $226K | ﹤0.01% |
50,113
+900
| +2% | +$3.87K |
|
3104
MetroCity Bankshares
MCBS
$1.03B
| $224K | ﹤0.01% |
8,094
-10,155
| -56% | -$295K |
|
|
ASPSZ
3105
Altisource Portfolio Solutions SA Cash Exercise Stakeholder Warrants
ASPSZ
$7.93M
| $224K | ﹤0.01% |
386,322
-31,200
| -7% | -$22.9K |
|
|
AHG
3106
Akso Health Group
AHG
$1.23B
| $224K | ﹤0.01% |
129,198
-1,600
| -1% | -$2.76K |
|
3107
Gain Therapeutics
GANX
$75.1M
| $223K | ﹤0.01% |
126,100
+32,100
| +34% | +$54.1K |
|
3108
abrdn Bloomberg All Commodity Strategy K-1 Free ETF
BCI
$2.9B
| $222K | ﹤0.01% |
10,300
-49,000
| -83% | -$1.03M |
|
|
SIFY
3109
Sify Technologies
SIFY
$1.14B
| $221K | ﹤0.01% |
+16,200
| New | +$137K |
|
|
PBBK
3110
DELISTED
PB Bankshares
PBBK
| $221K | ﹤0.01% |
+11,500
| New | +$217K |
|
|
RJET
3111
Republic Airways Holdings
RJET
$1.03B
| $218K | ﹤0.01% |
11,186
+4,506
| +67% | +$79.6K |
|
3112
CalciMedica
CALC
$12.6M
| $215K | ﹤0.01% |
70,000
+34,000
| +94% | +$97.8K |
|
3113
Hingham Institution for Saving
HIFS
$668M
| $215K | ﹤0.01% |
816
-6,373
| -89% | -$1.7M |
|
|
LONA
3114
LeonaBio Inc
LONA
$72M
| $215K | ﹤0.01% |
51,924
+27,824
| +115% | +$109K |
|
|
FMFC
3115
Kandal M Venture Ltd
FMFC
$5.41M
| $215K | ﹤0.01% |
+14,600
| New | +$131K |
|
|
BKV
3116
BKV Corp
BKV
$2.55B
| $213K | ﹤0.01% |
9,200
-30,600
| -77% | -$667K |
|
|
DRUG
3117
Bright Minds Biosciences
DRUG
$759M
| $212K | ﹤0.01% |
+3,500
| New | +$136K |
|
3118
Freightos
CRGO
$68.7M
| $211K | ﹤0.01% |
63,900
+18,000
| +39% | +$53.9K |
|
3119
Cardiff Oncology
CRDF
$72.3M
| $210K | ﹤0.01% |
101,800
-27,890
| -22% | -$77.1K |
|
3120
ExxonMobil
XOM
$638B
| $209K | ﹤0.01% |
1,865
-495,117
| -100% | -$55M |
|
3121
Avalon Holdings
AWX
$9.83M
| $209K | ﹤0.01% |
80,210
-3,775
| -4% | -$9.53K |
|
|
SSKN
3122
DELISTED
Strata Skin Sciences
SSKN
| $209K | ﹤0.01% |
101,530
+3,500
| +4% | +$6.94K |
|
3123
Xenon Pharmaceuticals
XENE
$6.19B
| $209K | ﹤0.01% |
5,200
-3,400
| -40% | -$120K |
|
|
LNKB
3124
DELISTED
LINKBANCORP
LNKB
| $208K | ﹤0.01% |
29,200
+10,800
| +59% | +$78.3K |
|
|
BLTE
3125
Belite Bio
BLTE
$6.3B
| $208K | ﹤0.01% |
2,812
-1,488
| -35% | -$97.7K |
|
Similar funds
Renaissance Technologies's Q3 2025 Portfolio in Review
As of Q3 2025, Renaissance Technologies held 4,038 positions worth $75.8B, up 0.77% from $75.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies withdrew a net $5.41B in Q3 2025, closing 581 positions and reducing 1,457 holdings. Its most notable exit was GE Aerospace, an estimated $235M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Alphabet (Google) Class C worth $419M.
- Renaissance Technologies's largest Q3 2025 buy was Alphabet (Google) Class C: 1,720,002 shares worth $419M.
- Renaissance Technologies added most to Alphabet (Google) Class A in Q3 2025, an estimated $546M increase.
- Renaissance Technologies's biggest Q3 2025 reduction was Robinhood, cutting an estimated $1.04B.
- Renaissance Technologies fully exited GE Aerospace in Q3 2025, selling an estimated $235M.
- Renaissance Technologies's ten largest holdings make up 11% of its $75.8B portfolio in Q3 2025.
- Renaissance Technologies opened 516 new positions and closed 581 in Q3 2025.
- Renaissance Technologies's portfolio value rose 0.77% quarter-over-quarter to $75.8B.
Based on Renaissance Technologies's 13F filing for Q3 2025, filed 13 Nov 2025.